Is Orchid Pharma Turnaround Candidate?
Shaikhoology's Stock Analysis
#OrchidPhar - 474
Overview:-
Business got into trouble and filed insolvency which was taken over by Dhanuka Laboratories in 2020
MOAT- Company have few patented products (API)
Topline:-
YOY & QOQ improvement seen in recent results.
Profit Growth is Organic and Margin Expansion clearly visible
BottomLine :-
Debt reduction, Good Reserves and Positive Cash Flow shows Financial stability.
Valuations:-
Overvalued as of Now.
If Earning Growth Continues then valuations can be cheaper, needs EPS of 10-15 then stock price will attract new investors.
Technically - Chart is bullish at Cmp and their is hurdles also as trading in WDZ
Stock May See 1000-1200 levels(WSZ) if trades and sustains above 550 levels.
SHARED FOR EDUCATIONAL PURPOSE ONLY, I AM NOT SEBI REGISTERED ANALYST.
#OrchidPhar - 474
Overview:-
Business got into trouble and filed insolvency which was taken over by Dhanuka Laboratories in 2020
MOAT- Company have few patented products (API)
Topline:-
YOY & QOQ improvement seen in recent results.
Profit Growth is Organic and Margin Expansion clearly visible
BottomLine :-
Debt reduction, Good Reserves and Positive Cash Flow shows Financial stability.
Valuations:-
Overvalued as of Now.
If Earning Growth Continues then valuations can be cheaper, needs EPS of 10-15 then stock price will attract new investors.
Technically - Chart is bullish at Cmp and their is hurdles also as trading in WDZ
Stock May See 1000-1200 levels(WSZ) if trades and sustains above 550 levels.
SHARED FOR EDUCATIONAL PURPOSE ONLY, I AM NOT SEBI REGISTERED ANALYST.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.